PURA Is Cannabis Acquisition Candidate According To Analyst Report Indicating $0.35 PPS Potential

New York, NY -- February 28, 2019 -- InvestorsHub NewsWire -- via NextBigTicker.com -- Goldman Small Cap Research issued a research update on Puration, Inc. (USOTC: PURA) recommending a 'speculative-buy' rating with a target price-per-share of $0.25, with noted potential upside to the $0.35 mark.

PURA has released major news this week with the debut of its all new EVERx CBD Sports Water at the Arnold Sports Festival starting today in Columbus, Ohio. In reaction to the announcement the share price has more than doubled hitting a high of $0.15 on over 100 million shares of trading volume over the course of two days. The PPS has retraced as of this writing to $0.11 on less than half of the trading volume that took the price up. The PPS is showing healthy consolidation and building a base to head toward the analyst indicated upside potential of $0.35

“There is substantial interest in hemp-derived CBD-infused products, as evidenced by the flurry of M&A, investment activity and talk by major beverage companies such as Constellation, Brands (STZ), Diageo, Tilray (TLRY), Coca-Cola (COKE), Starbucks, etc. Once critical mass of sales is achieved, given its broad popularity, PURA could emerge as an M&A target,” concluded Goldman.

Find Goldman’s full update report below:

Published by NextBigTicker.com